NYSE:SLQT SelectQuote Q3 2025 Earnings Report $2.18 -0.01 (-0.46%) Closing price 05/30/2025 03:59 PM EasternExtended Trading$2.17 -0.01 (-0.46%) As of 05/30/2025 07:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. ProfileEarnings HistoryForecast SelectQuote EPS ResultsActual EPS$0.03Consensus EPS $0.04Beat/MissMissed by -$0.01One Year Ago EPSN/ASelectQuote Revenue ResultsActual Revenue$408.16 millionExpected Revenue$412.83 millionBeat/MissMissed by -$4.67 millionYoY Revenue GrowthN/ASelectQuote Announcement DetailsQuarterQ3 2025Date5/12/2025TimeBefore Market OpensConference Call DateMonday, May 12, 2025Conference Call Time8:30AM ETConference Call ResourcesConference Call AudioConference Call TranscriptSlide DeckPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfileSlide DeckFull Screen Slide DeckPowered by SelectQuote Q3 2025 Earnings Call TranscriptProvided by QuartrMay 12, 2025 ShareLink copied to clipboard.PresentationSkip to Participants Operator00:00:00Welcome to SelectQuote's Third Quarter Earnings Conference Call. Operator00:00:03All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer It is now my pleasure to introduce Matt Gunther, SelectQuote Investor Relations. Mr. Gunther, you may begin the conference. Matthew GunterChief Communication Officer & Investor Relations at SelectQuote00:00:26Thank you, and good morning, everyone. Welcome to SelectQuote's fiscal third quarter earnings call. Before we begin our call, I would like to mention that on our website, we have provided a slide presentation to help guide our discussion. After today's call, a replay will also be available on our website. Joining me from the company, I have our Chief Executive Officer, Tim Danker and Chief Financial Officer, Ryan Clement. Matthew GunterChief Communication Officer & Investor Relations at SelectQuote00:00:50Following Tim and Ryan's comments today, we will have a question and answer session. As referenced on Slide two during this call, we will be discussing some non GAAP financial measures. The most directly comparable GAAP financial measures and a reconciliation of the differences between the GAAP and non GAAP financial measures are available in our earnings release and investor presentation on our website. And finally, a reminder that certain statements made today may be forward looking statements. These statements are made based upon management's current expectations and beliefs concerning future events impacting the company and therefore involve a number of uncertainties and risks, including but not limited to those described in our earnings release, quarterly report on Form 10 Q for the period ended 03/31/2025 and other filings with the SEC. Matthew GunterChief Communication Officer & Investor Relations at SelectQuote00:01:42Therefore, the actual results of operations or financial condition of the company could differ materially from those expressed or implied in our forward looking statements. And with that, I'd like to turn the call over to our Chief Executive Officer, Tim Danker. Tim? Timothy DankerChief Executive Office at SelectQuote00:01:59Thank you, Matt, and thanks to everyone joining us today. SelectQuote continued to drive strong results in fiscal twenty twenty five and had another successful quarter across each of our three segments: Senior, Healthcare Services and Life Insurance. On a consolidated basis, our fiscal third quarter revenues of $4.00 $8,000,000 grew by 8% compared to a year ago. The growth was again driven by very strong member onboarding in our SelectRx business, which now has nearly 106,000 members, representing a 41% increase compared to a year ago. It's remarkable to us that the business has nearly $675,000,000 and trailing twelve month revenues that only started four years ago with two small pharmacies that had approximately $20,000,000 in revenues and fewer than 5,000 members at the time of acquisition. Timothy DankerChief Executive Office at SelectQuote00:02:49The business' rapid success remains a touchstone example of how SelectQuote can drive value for customers through personalized coordination of information and service delivery. Our consolidated EBITDA of $38,000,000 in the quarter demonstrates strong execution across our segments as we maintain healthy overall margins despite a large shift in our mix between senior and healthcare services. Mix shift was again a factor in the pace of our consolidated EBITDA growth relative revenue, given lower relative margins in Healthcare Services compared to Senior. We're proud of the result and believe there remains significant EBITDA opportunity in both our Senior and our Healthcare Services segments. I'll speak more to our strategic focus on Healthcare Services as a source of profit and cash flow later in my remarks. Timothy DankerChief Executive Office at SelectQuote00:03:40As mentioned, third quarter operating highlights were strong across each of our three segments. Senior delivered healthy 27% margins for the third quarter, which is very strong considering such a unique and tumultuous Medicare Advantage season. As we indicated on prior calls, given a more restricted capital structure last summer, we did not hire as large of a class as we normally would have in this environment. So we're especially proud of our execution given we operated an agent force that was 26% smaller this season, which dampened volumes. I'll touch on senior and the Medicare Advantage environment as a whole in just a minute. Timothy DankerChief Executive Office at SelectQuote00:04:19Along with others in the industry, we were pleased to see the higher than anticipated final rate notice that came through in April for the 2026 plan year. We believe the increase will progressively help carriers with the Medicare Advantage pressures they faced in the most recent season. For SelectQuote, we expect these higher carrier reimbursement levels to create a less disruptive market backdrop for our customer base and seniors more broadly as we prepare for the next AEP. Turning to Healthcare Services, we delivered strong profitability despite rapid growth. As I alluded to earlier, we believe the scale of our membership now provides SelectQuote with a great foundation and we see an opportunity to drive more consistent margins and cash flows going forward. Timothy DankerChief Executive Office at SelectQuote00:05:05In our Life Insurance business, we drove another impressive quarter on both the top and bottom line. Life revenues grew 13% and profits more than doubled compared to a year ago. The business continues to drive a stable and strong source of EBITDA margin profitability and a highly visible source of cash flow. Across our entire platform, SelectQuote continues to generate highly attractive revenue compared to the cost to acquire customers. For the third quarter, our trailing twelve month revenue to CAC was 5.8x, which compares to 4.2x a year ago. Timothy DankerChief Executive Office at SelectQuote00:05:40We take a lot of pride in this metric as the financial barometer of SelectQuote's overall marketing efficiency and as an indicator of the value we provide to our customer base. When we leverage our superior data and agent led capabilities, our customers receive better service and care. Clearly, the economic outcome is good for our business, but the metric is especially rewarding given the tangible benefit to Americans, particularly in what has been a volatile and confusing year for healthcare policy. SelectQuote continues to solidify our reputation and the healthcare ecosystem as a trusted and valuable partner, which is more important now than ever. Now on Slide four, let me focus on Medicare Advantage and SelectQuote's performance through the OEP period. Timothy DankerChief Executive Office at SelectQuote00:06:26As noted, we're very pleased with our execution through such a unique and challenging Medicare Advantage season. While our agent force was smaller compared to a year ago, the team drove impressive volume and efficiency results. Third quarter policies totaled $168,000 down less than 10% compared to an agent force that was 26% smaller. As we noted last quarter, carrier plan terminations and significant changes to policy features created noise and decision stress for seniors this Medicare Advantage season. That backdrop made our agent led model all the more important. Timothy DankerChief Executive Office at SelectQuote00:07:02We're very proud that we were able to help so many people. Even more impressive are the efficiency and profitability improvements in senior during 3Q. As you can see at the right of this page, our strong close rates year to date serve as a testament to how our technology arms our agents with new data and tools in each unique season. Looking forward to fourth quarter, as we exit the OEP season, we're refining our approach due to the introduction of changes to beneficiary eligibility during the special election period. Although we're pleased with the continued performance of our agents, these industry changes present a headwind to close rates and volume relative to prior years. Timothy DankerChief Executive Office at SelectQuote00:07:43In addition to throughput, our senior segment also drove efficiency across both marketing and operating expenses. Marketing expenses per approved policy was down 9% and overall operating expenses per policy were down four percent. We focus each season on optimal profitability, but are especially proud of our operating expense performance given a lower year for policy volume. Again, SelectQuote's technology and information advantages continue to benefit our overall business, not just through incremental revenue opportunity, but also through operating efficiency. The combination of each of these factors contributed to the strong 27% adjusted EBITDA margins despite lower year over year policy volume. Timothy DankerChief Executive Office at SelectQuote00:08:29For a year where Medicare Advantage posed challenges for many industry participants, we're proud that our platform not only succeeded, but improved on a very strong fiscal twenty twenty four. Specifically, our year to date senior margins are currently at 30%, which compares to 26% at this point last year. The past three years' results across a wide range of selling seasons gives us a great deal of conviction and our ability to consistently drive profit margins above our long term target of 20%. On Slide five, I'd like to expand on our plan to drive higher profitability in our Healthcare Services segment. As I noted, we believe 106,000 members and our SelectRx business represents critical mass. Timothy DankerChief Executive Office at SelectQuote00:09:15Having created a revenue base of nearly $675,000,000 over the past year, we see an opportunity to focus on generating more consistent margins and cash flows to drive shareholder value. As we've discussed, SelectRX profitability has lagged membership and revenue, given growth investment and the seasoning of our member base. We're proud of the progress we've made to date, but believe there is an opportunity to better identify the customers who will benefit from the SelectRx offering the most. You have heard us speak to the ramp of SelectRx members to full box shipments. While that continues to be a focus for new members, we've also observed a wide range of customer use cases. Timothy DankerChief Executive Office at SelectQuote00:09:54We'll share more when we speak to our 2026 outlook, but we believe there's an opportunity to align SelectRx's best service attributes with those Americans that need us the most. Over the remainder of fiscal twenty twenty five and into fiscal twenty twenty six, we plan to increase the mix of members that benefit most from SelectRx, who typically also have the most attractive unit economics. Now that we've achieved meaningful scale, our primary goal will be to increase efficiency and build a more consistent margin profile for the business. In the near term, this will likely translate to slower membership growth. As we've announced last September, membership and volume growth required additional investment in facility expansion with the opening of our Olathe facility here in Kansas, which shipped its first box on April 7. Timothy DankerChief Executive Office at SelectQuote00:10:43In the medium and long term, we believe the scale and efficiency gains of this new facility will be accretive, but we expect the near term headwind to profitability, which will dampen our fourth quarter results. Ryan will share more about the pacing of this dynamic in our outlook, but I'll close this topic by emphasizing three unchanged attributes about SelectRx and our healthcare services capabilities. First, our SelectRx members drive visible revenue and cash flow. It has been clear to us that the value of our medication management adherence solution is widely proven. Our job now is to improve efficiency and drive a more consistent margin profile for the business. Timothy DankerChief Executive Office at SelectQuote00:11:23Second, regardless of the membership mix, there remains significant operating leverage potential in healthcare services, which should continue to grow as we broaden our value added service offering. Third, while less visible, we know from our policyholders and agents that there's a halo effect to the differentiated value we deliver. Policyholders that are also SelectRX members become further attached to SelectQuote. As a result, insurance providers and caregivers increasingly seek us out for partnership. In the past, we've called this concept a healthcare information hub or flywheel. Timothy DankerChief Executive Office at SelectQuote00:11:57Whatever we call it, we know that it is a reality with our customers and partners. Finally, before I turn the call over to Ryan, I'd like to briefly comment on the Department of Justice complaint that was recently filed against many participants in the Medicare Advantage system. We've been cooperating fully with the Department of Justice's inquiries since we first received the previously disclosed subpoena in 2022. However, we firmly reject these allegations, which we believe represent a misunderstanding of our industry and our business. We plan to mount a vigorous defense as this case moves forward. Timothy DankerChief Executive Office at SelectQuote00:12:33SelectQuote has a forty year history as a high integrity organization that has helped millions of Americans find the right coverage for their health needs. Additionally, we've invested significant capital into compliance across our whole organization from our agents to our management and take significant measures to fully comply with all federal laws and regulations. I assure you that the culture at SelectQuote is one where the customers' needs are prioritized. We look forward to detailing this history as the matter develops. We've always been and we will continue to be a compliant and fair dealing standard bearer in the Medicare Advantage industry. Timothy DankerChief Executive Office at SelectQuote00:13:12We will continue to deliver high quality advice to the customers we help to navigate the complicated array of Medicare health plan options. This is obviously an active legal matter, so we won't be commenting further on any particulars at this point. And with that, I'd like to hand the call over to Ryan. Ryan? Ryan ClementChief Financial Officer at SelectQuote00:13:31Thanks, Tim. Starting on Slide six, SelectQuote generated $4.00 $8,000,000 in revenue for the third quarter, up 8% compared to a year ago. Similar to last quarter, our top line growth was driven by our SelectRx business, But as Tim mentioned, operating performance across each of our businesses was very strong. For senior specifically, the OEP period was similar to AEP where agents delivered higher Medicare Advantage volumes than originally forecasted, driven by impressive productivity and close rates. Consolidated adjusted EBITDA totaled $38,000,000 for an overall margin of 9%. Ryan ClementChief Financial Officer at SelectQuote00:14:07We are pleased to have maintained healthy consolidated margins despite a significant mix shift from the growth in SelectRx, which is still a lower margin business. As Tim noted, we see healthcare services as a strategic opportunity, not just for our new revenue streams, but for scaled profitability in the coming years. Moving to Slide seven. Our senior results were quite strong despite operating with a smaller agent population for the season. Revenue totaled $169,000,000 in Q3, driven by the strong agent efficiency we mentioned. Ryan ClementChief Financial Officer at SelectQuote00:14:41Similar to last quarter's AEP, we continue to see seniors seek our tenured agents for much needed answers in such a confusing and volatile Medicare Advantage backdrop. The end result with high value service to our customers, but also significant operating efficiency in both marketing and agent throughput. Put more plainly, more seniors came to us when they needed us most and our aligned model drove very strong margins. Our adjusted EBITDA in Q3 was $46,000,000 which declined by 26%, in line with the 26% reduction in agent headcount compared to last year. Despite a smaller agent population, the senior business drove attractive EBITDA margins of 27%. Ryan ClementChief Financial Officer at SelectQuote00:15:23The performance since our strategic redesign has exceeded our expectations in three distinctly different Medicare Advantage environments. As originally intended, our strategic redesign was undertaken to build a SelectQuote for all seasons. We firmly believe that goal has been achieved, and we see a highly durable value creation engine for customers and shareholders as a result. On Slide eight, I'll briefly review our senior operating performance. As mentioned, with a 26% reduction in our agent workforce compared to last year, we're very pleased with the increased agent level efficiency, which led to only a 10% decline in our Medicare Advantage approved policy generation. Ryan ClementChief Financial Officer at SelectQuote00:16:00The difference again was a combination of seniors proactively seeking us out and our tenured agents' ever improving ability to leverage SelectQuote's data and tools to provide the most effective and valuable service possible. We are proud of the division's strong results. It is worth noting, on the heels of meaningful progress on the capital structure, we've already begun planning for the next AEP and OEP seasons. Next, let me speak to LTV, which was $915,000,000 for Q3, down 8% compared to a year ago. The key driver was a shift in our commission structure. Ryan ClementChief Financial Officer at SelectQuote00:16:32For a select few carrier partners, you will recall that we had shifted to a higher mix of upfront commissions compared to what was historically been a ratable timeline. The changes in our modeled LTVs is the result of those upfront structures largely reverting back to ratable structures. On Slide nine, as Tim noted, our SelectRx membership continued to grow substantially in Q3. We ended the quarter with 106,000 members, up 41% compared to a year ago. As a result, healthcare services revenue of $190,000,000 grew 53% year over year and has a trailing full year revenue base of $674,000,000 Healthcare Services produced $6,000,000 of adjusted EBITDA, which we are very pleased with. Ryan ClementChief Financial Officer at SelectQuote00:17:16We will provide more detail on our outlook for Healthcare Services in fiscal twenty twenty six in our next earnings call. But as Tim noted, our goal is to drive improvements in both profitability and cash flow in the future. We have confidence in our economics and believe the medium term results will drive value for shareholders. On Slide 10, I'll end the segment review with our Life business, where we continue to be pleased with results. The business performed well on both the top line and from a cash flow perspective. Ryan ClementChief Financial Officer at SelectQuote00:17:44Revenue during the quarter was $46,000,000 and adjusted EBITDA was $6,000,000 which was up 103% year over year. EBITDA margins of 14% nearly doubled compared to 8% last year. Both our final expense and Term Life business contributed to the highly successful quarter with Term Life premiums up 13% and final expense premium up 17% year over year. These results were fueled by strong agent retention and a highly tenured agent force that drove both strong productivity and customer retention. Turning to Slide 11, I will conclude my remarks with an update to our fiscal twenty twenty five outlook. Ryan ClementChief Financial Officer at SelectQuote00:18:21We maintain our full year ranges for revenue and adjusted EBITDA. That said, we do expect to finish the year in or towards the lower half of the ranges based on the following. First, as Tim noted, new beneficiary eligibility parameters during the special election period could drive additional friction for policy volumes and close rates compared to previous seasons. Second, as we ramp our Kansas distribution facility and focus less on member growth and more on achieving consistent margins and cash flow, we could encounter near term headwinds to our healthcare services EBITDA. While accretive in the long term, we expect fiscal fourth quarter EBITDA to potentially take a modest step back. Ryan ClementChief Financial Officer at SelectQuote00:18:59In addition, fourth quarter growth will taper due to seasonal trends as we exit the AEP and OEP seasons. Lastly, we are adjusting our net income expectations to a range of negative $1,000,000 to $28,000,000 to reflect the impact the change in our stock price had on the fair market value of the warrants issued as part of the transactions announced during this fiscal year. I'll conclude by echoing Tim's comments about the strength and potential of our overall model. Fiscal twenty twenty five has been a year of significant progress and transition for our company. In addition to the strong growth and results in all three business lines, we have made meaningful progress on our capital structure, including the $100,000,000 securitization in October and the $350,000,000 strategic investment in February. Ryan ClementChief Financial Officer at SelectQuote00:19:43These deals have lowered our interest expense, extended our maturities and increased our available liquidity. We produced $71,000,000 in operating cash flow during the quarter and ended the quarter with an $86,000,000 cash balance. Our commissions receivable balance of over $1,000,000,000 remains a significant asset and source of future cash flows as we continue to evaluate additional alternatives to further optimize our capital structure. We are proud of the results we delivered this Medicare Advantage season and look forward to sharing updates on the planned scale of our sizable health care services opportunity. With that, we will open the call up for questions. Operator00:20:19Thank you. Ladies and gentlemen, we will now begin the question and answer session. Session. Your first question comes from the line of George Sutton with Craig Hallum. Please go ahead. George SuttonPartner & Senior Research Analyst at Craig-Hallum Capital Group LLC00:20:48Thank you. I wondered if you could walk through the separation of the growth or the decline you saw in Medicare Advantage and obviously the significant growth of SelectRx. And I'm asking from the concept of the feeder of customer opportunities into SelectRx and any adjustments that you might be making there going forward? Timothy DankerChief Executive Office at SelectQuote00:21:13Yeah. I'd be happy to. Good morning, George. Thanks for the call. I think on this two part question, I'm gonna ask our president, Bob Grant, to talk about our Medicare dynamics. Timothy DankerChief Executive Office at SelectQuote00:21:23I'm happy to touch on health care as well. Bob? Robert GrantPresident at SelectQuote00:21:27Yeah. So on the Medicare side, George, SEP was or sorry. OEP was was a really strong quarter for us from a overall close rate perspective and and cost. But but to Ryan's point earlier, we were down 26% on our agent count, which is why we ended up, you know, seeing a little bit lower volume and lower overall EBITDA there. However, one of the reasons for such a strong quarter, which Tim will get into health care services from a growth perspective in the SRX space, is we did have a lot more tenured agents. Robert GrantPresident at SelectQuote00:22:04And we've been very open in the past that they are better at understanding how to deal with customers' needs both on sales and folks that don't buy a policy where they end up transferring them over to health care services. So we did see a little stronger, what I would say, attachment rate or just overall efficiency in that number, which is why you saw one kind of outpace the other. So that also helps our attachment rates in a good way on the the customers that really, really need SelectRX, and and we see that as a as a positive. So that that's why you saw what you saw there. Tim can broadly speak about health care services, but from direct to your question, the reason we didn't see kind of the reduction in both on the growth side was that. Timothy DankerChief Executive Office at SelectQuote00:22:47Yeah. Yeah. Just to add to Bob's good comments there. I mean, overall, we're really pleased with the ability of the model to, you know, leverage our strong m MA growth and have that translate into opportunities for our health care services platform. I think you've seen that through the growth of, you know, critical mass not over a hundred thousand members. Timothy DankerChief Executive Office at SelectQuote00:23:09We will, you know, anticipate, though, that senior health care services will lag our senior just a bit and just in terms of timing, and there is some seasonality that we called out as well. But overall, real really pleased with the the synergy between both sides of the platform. George SuttonPartner & Senior Research Analyst at Craig-Hallum Capital Group LLC00:23:30So I wondered if you can give us thoughts on agent growth going into this next season. Are the plans to take advantage of improvements in that market, particularly from a regulatory perspective? Robert GrantPresident at SelectQuote00:23:48Yeah. Great question. Tiring is underway right now. You know, it's not gonna be the same as as last year per se, but we will talk way more about that in our upcoming guide on the next call. So we feel good about where we are with hiring, though. Timothy DankerChief Executive Office at SelectQuote00:24:05Then Certainly, as we highlighted yeah. George, real quick. Certainly, as we highlighted on the last call, I think the improved capital position that we're in, you know, gives us an opportunity. We're very focused and feel good about where we're at in the early stages of of hiring and and do look forward to sharing more on our fiscal twenty six guide in August. George SuttonPartner & Senior Research Analyst at Craig-Hallum Capital Group LLC00:24:26And then just finishing up on your better financials. Can you talk about receivable securitization? My anticipation has been that we might see additional receivable securitization. Ryan ClementChief Financial Officer at SelectQuote00:24:39Yeah. Great question, George. Obviously, we've we've made great progress, you know, on on the capital structure more broadly with the first securitization. We've been obviously focused on getting the prep across the finish line, which we're happy to share with our last earnings call. And we've, you know, we've hired Jeffries to explore a variety of options. Ryan ClementChief Financial Officer at SelectQuote00:24:59We do see securitization as a potential path. It's not the only path. We look forward to sharing additional updates when the time is right, but we do have several irons in the fire. George SuttonPartner & Senior Research Analyst at Craig-Hallum Capital Group LLC00:25:11Guys. Operator00:25:14Your Operator00:25:15next question comes from the line of Ben Hendrix with RBC Capital Markets. Please go ahead. Michael MurrayEquity Research Associate at RBC Capital Markets00:25:23Hi. This is Michael Murray on for Ben. Appreciate your commentary on MA LTV and the impact of the shifting commission structure. Just wanted to see how should we think about MA LTV moving forward? Do you anticipate an ongoing headwind as the shift continues? Michael MurrayEquity Research Associate at RBC Capital Markets00:25:39Thanks. Ryan ClementChief Financial Officer at SelectQuote00:25:43Yeah. So we, I mean, as as you noted, yeah, we did see a shift, from upfront to ratable, which did lead to a decline. That's simply a continuation of changes we had announced in prior quarters. All that said, we do expect, you know, in the fourth quarter, it will be down year over year. You know, we'll look forward to sharing additional details, on our longer term outlook, you know, on our next earnings call. Ryan ClementChief Financial Officer at SelectQuote00:26:08But, in fourth quarter, we do expect it to be down year over year. Michael MurrayEquity Research Associate at RBC Capital Markets00:26:14Okay. And then just shifting to SelectRX, obviously, another great quarter. It's exciting to hear about the new facility opening in Kansas. Obviously, we heard your commentary on fourth quarter margin expectations. But just longer term, bigger picture, how should investors, think about the growth and margin targets, for this business? Michael MurrayEquity Research Associate at RBC Capital Markets00:26:38Thanks. Timothy DankerChief Executive Office at SelectQuote00:26:40Yes, Michael, I'll I'll comment on that, and and Ryan, have you add to it here. But, yeah, I do think just stepping back, you know, we're really pleased with the progress. We've got critical, you know, critical mass and scale here with over a hundred thousand patients. And so I think we'd ask investors to to also think that part of our job now is to further prioritize, efficiency and consistency of margins. So we are spending a lot of time, focused on that and and analyzing that, and I think we are finding that those, you know, members that generally benefit the most from our adherence solution also have the best unit economics. Timothy DankerChief Executive Office at SelectQuote00:27:21Again, customers with multiple products, they're juggling a lot of prescription drugs. And so we're seeing some opportunities to refine that so that we can drive, even improved margins and cash flow profile. We had mentioned on the call, you know, some investment in the Kansas facility. You know, we think longer term, that is certainly gonna drive these efficiency gains, but there is some, you know, near term costs there in the fourth quarter as we as we scale that up. Ryan? Ryan ClementChief Financial Officer at SelectQuote00:27:53No. You said it well. Yeah. Think for the fiscal twenty twenty five, we still expect single digit EBITDA margins for the year. And as we refine our membership parameters and scale the cadence, we do see a path to margin enhancement and expansion in future quarters. Michael MurrayEquity Research Associate at RBC Capital Markets00:28:12All right. Thank you. Operator00:28:16Your next question comes from the line of Pat McCann with Noble Capital Markets. Please go ahead. Patrick McCannEquity Research Analyst at Noble Capital Markets00:28:23Hey, guys. Thanks for taking my questions. I wanted to ask about the final rate notice. Could you I know it's early, but could you give your kind of your view on how you think the the upcoming AEP, how the environment should look relative to the one that we just came out of as far as market dynamics. What would be your early read given the final rate notice and how that changes? Patrick McCannEquity Research Analyst at Noble Capital Markets00:28:53Thanks. Timothy DankerChief Executive Office at SelectQuote00:28:55Good morning, Pat. Great question. We definitely believe the final rate notice was a positive development as the carrier reimbursement rates were substantially higher than the preliminary rates. As we've been in discussions with carriers, they definitely had felt like this was a step in the right direction. This helps improve revenues. Timothy DankerChief Executive Office at SelectQuote00:29:18And you've heard many carriers commented on higher medical cost trends and elevated plan utilization. So we certainly view that as a positive development. We would say to the carriers, some carriers are still focused on increasing margins. They're in the middle innings of a multiyear plan to get to their target profitability, but we certainly believe this is a positive development. Bob, anything you'd like to add? Robert GrantPresident at SelectQuote00:29:45No. I mean, I I think that, to Tim's point, it Robert GrantPresident at SelectQuote00:29:50was a little bit, I think, up in Robert GrantPresident at SelectQuote00:29:52the air as far as what CMS was gonna do, right, just coming in, early and then also the rate, they feel it, frankly, get a little bit higher too in December, I think, than people anticipated. But it was great that they took into account this year versus a lagging year like they had in the past with where inflation's gone and other things. So I I think those, that CMS has support, for the private side of Medicare. Now do they wanna clean some things up that we're very supportive of, frankly, as far as making sure that everyone has access to quality health care, especially a lot of the focus that we have, which we've talked about in the past, rural areas, things like that, yes. But as far as just the advanced rate notice and the rate notice, very positive from all kind of sides. Patrick McCannEquity Research Analyst at Noble Capital Markets00:30:37Thanks. And then I just wanted to briefly touch on the Healthcare Services segment. First of all, congrats on opening the new facility. And with that, I'm wondering maybe if you could reiterate the benefits you expect to realize, the incremental benefits from that facility as well as maybe if you could touch on the profitability drag that you mentioned for fiscal Q4. And would that go beyond Q4? Patrick McCannEquity Research Analyst at Noble Capital Markets00:31:13Or what's sort of the timeframe for the initial drag on profitability before you sort of get through that? Thanks. Ryan ClementChief Financial Officer at SelectQuote00:31:27Yeah. So with respect to the Kansas facility, we're obviously really excited about having it open. And longer term, you know, see benefits in operating efficiency, throughput, and even customer experience. You know, with that all being said, there is a short term lag as in terms of profitability or drag on profitability as a result of simply, you know, investments into the facility. As we scale up, we will outgrow, and we'll we'll see margin expansion. Ryan ClementChief Financial Officer at SelectQuote00:31:57But in the near term, you know, I think on a quarterly basis, you can think of it as low single digit million dollar investment. And again, that will scale into it over the next couple of quarters. Patrick McCannEquity Research Analyst at Noble Capital Markets00:32:09Great. Thanks, guys. That's all I had. I'll jump back in the queue. 00:32:33I will now turn the call back over to Tim for closing remarks. Timothy DankerChief Executive Office at SelectQuote00:32:39Thank you, everyone, and we appreciate your time and support this morning. Most of all, thank you to our incredible teams at SelectQuote for another season of world class service and execution. Our customers needed you more than ever this year. And because of our high touch and information driven approach, they received the help they needed and our business benefited as well. Looking ahead, we're energized and have conviction that our overall business can generate additional operating leverage and resulting value to our shareholders. Timothy DankerChief Executive Office at SelectQuote00:33:09We'll share more on our view for fiscal twenty twenty six on the next call and hope to see and speak to many of you between now and then. Thank you again for your time this morning. Have a good day. 00:33:21Ladies and gentlemen, that concludes today's call. Thank you all for joining. You may now disconnect.Read moreParticipantsExecutivesMatthew GunterChief Communication Officer & Investor RelationsTimothy DankerChief Executive OfficeRyan ClementChief Financial OfficerAnalystsGeorge SuttonPartner & Senior Research Analyst at Craig-Hallum Capital Group LLCRobert GrantPresident at SelectQuoteMichael MurrayEquity Research Associate at RBC Capital MarketsPatrick McCannEquity Research Analyst at Noble Capital MarketsPowered by Key Takeaways SelectQuote reported Q3 fiscal 2025 revenue of $408 million (up 8% YoY) and consolidated adjusted EBITDA of $38 million, driven by strong member onboarding in the SelectRx business. The Senior segment delivered revenue of $169 million with a 27% adjusted EBITDA margin despite operating with 26% fewer agents and less than a 10% decline in approved policies. SelectRx membership grew 41% YoY to 106,000 members supporting $190 million in Q3 revenue; management plans near-term margin headwinds from ramping a new Kansas facility while targeting improved unit economics over time. The Life Insurance segment saw 13% revenue growth to $46 million and doubled profits (103% EBITDA increase) to $6 million, with margins rising to 14% on strong agent retention and productivity. Capital structure enhancements include a $100 million securitization, a $350 million strategic investment, $86 million cash on hand, and over $1 billion in commissions receivable, with further securitization options under review. AI Generated. May Contain Errors.Conference Call Audio Live Call not available Earnings Conference CallSelectQuote Q3 202500:00 / 00:00Speed:1x1.25x1.5x2xTranscript SectionsPresentationParticipants Earnings DocumentsSlide DeckPress Release(8-K)Quarterly report(10-Q) SelectQuote Earnings HeadlinesSelectQuote, Inc. Investor News: If You Have Suffered Losses in SelectQuote, Inc. (NYSE: SLQT), You Are Encouraged to Contact The Rosen Law Firm About Your RightsMay 30 at 12:30 PM | globenewswire.comSelectQuote (SLQT) Shares Slide Further on Disappointing Earnings Amidst DOJ Scrutiny- Hagens BermanMay 29 at 1:47 PM | prnewswire.comThe Social Security Changes No One’s Talking AboutWhile most Americans worry about their next Social Security check... something far bigger is happening behind the scenes. An AI plan — authorized by Executive Order — is about to rewrite how the SSA operates.June 1, 2025 | Altimetry (Ad)SelectQuote’s Highly-Satisfied Insurance Customers Award the Company a Net Promoter Score of 58, Considered “Great”May 28, 2025 | businesswire.comRosen Law Firm Encourages SelectQuote, Inc. Investors to Inquire About Securities Class Action Investigation - SLQTMay 28, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SelectQuote, Inc. - SLQTMay 28, 2025 | globenewswire.comSee More SelectQuote Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like SelectQuote? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SelectQuote and other key companies, straight to your email. Email Address About SelectQuoteSelectQuote (NYSE:SLQT) operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies. The company also provides SelectRx, an accredited patient-centered pharmacy home pharmacy, which offers essential prescription medications, OTC medications, customized medication packaging, medication therapy management, and long-term pharmacy care; and population health that helps members understand the benefits available under their health plans, and contracts with insurance carriers. SelectQuote, Inc. was incorporated in 1999 and is headquartered in Overland Park, Kansas.View SelectQuote ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles e.l.f. Beauty Sees Record Surge After Earnings, Rhode DealCrowdStrike Stock Slips: Analyst Downgrades Before Earnings Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsAdvance Auto Parts: Did Earnings Defuse Tariff Concerns?Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockAdvance Auto Parts Jumps on Surprise Earnings BeatAlibaba's Earnings Just Changed Everything for the Stock Upcoming Earnings CrowdStrike (6/3/2025)Haleon (6/4/2025)Broadcom (6/5/2025)Oracle (6/10/2025)Adobe (6/12/2025)Accenture (6/20/2025)FedEx (6/24/2025)Micron Technology (6/25/2025)Paychex (6/25/2025)NIKE (6/26/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PresentationSkip to Participants Operator00:00:00Welcome to SelectQuote's Third Quarter Earnings Conference Call. Operator00:00:03All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer It is now my pleasure to introduce Matt Gunther, SelectQuote Investor Relations. Mr. Gunther, you may begin the conference. Matthew GunterChief Communication Officer & Investor Relations at SelectQuote00:00:26Thank you, and good morning, everyone. Welcome to SelectQuote's fiscal third quarter earnings call. Before we begin our call, I would like to mention that on our website, we have provided a slide presentation to help guide our discussion. After today's call, a replay will also be available on our website. Joining me from the company, I have our Chief Executive Officer, Tim Danker and Chief Financial Officer, Ryan Clement. Matthew GunterChief Communication Officer & Investor Relations at SelectQuote00:00:50Following Tim and Ryan's comments today, we will have a question and answer session. As referenced on Slide two during this call, we will be discussing some non GAAP financial measures. The most directly comparable GAAP financial measures and a reconciliation of the differences between the GAAP and non GAAP financial measures are available in our earnings release and investor presentation on our website. And finally, a reminder that certain statements made today may be forward looking statements. These statements are made based upon management's current expectations and beliefs concerning future events impacting the company and therefore involve a number of uncertainties and risks, including but not limited to those described in our earnings release, quarterly report on Form 10 Q for the period ended 03/31/2025 and other filings with the SEC. Matthew GunterChief Communication Officer & Investor Relations at SelectQuote00:01:42Therefore, the actual results of operations or financial condition of the company could differ materially from those expressed or implied in our forward looking statements. And with that, I'd like to turn the call over to our Chief Executive Officer, Tim Danker. Tim? Timothy DankerChief Executive Office at SelectQuote00:01:59Thank you, Matt, and thanks to everyone joining us today. SelectQuote continued to drive strong results in fiscal twenty twenty five and had another successful quarter across each of our three segments: Senior, Healthcare Services and Life Insurance. On a consolidated basis, our fiscal third quarter revenues of $4.00 $8,000,000 grew by 8% compared to a year ago. The growth was again driven by very strong member onboarding in our SelectRx business, which now has nearly 106,000 members, representing a 41% increase compared to a year ago. It's remarkable to us that the business has nearly $675,000,000 and trailing twelve month revenues that only started four years ago with two small pharmacies that had approximately $20,000,000 in revenues and fewer than 5,000 members at the time of acquisition. Timothy DankerChief Executive Office at SelectQuote00:02:49The business' rapid success remains a touchstone example of how SelectQuote can drive value for customers through personalized coordination of information and service delivery. Our consolidated EBITDA of $38,000,000 in the quarter demonstrates strong execution across our segments as we maintain healthy overall margins despite a large shift in our mix between senior and healthcare services. Mix shift was again a factor in the pace of our consolidated EBITDA growth relative revenue, given lower relative margins in Healthcare Services compared to Senior. We're proud of the result and believe there remains significant EBITDA opportunity in both our Senior and our Healthcare Services segments. I'll speak more to our strategic focus on Healthcare Services as a source of profit and cash flow later in my remarks. Timothy DankerChief Executive Office at SelectQuote00:03:40As mentioned, third quarter operating highlights were strong across each of our three segments. Senior delivered healthy 27% margins for the third quarter, which is very strong considering such a unique and tumultuous Medicare Advantage season. As we indicated on prior calls, given a more restricted capital structure last summer, we did not hire as large of a class as we normally would have in this environment. So we're especially proud of our execution given we operated an agent force that was 26% smaller this season, which dampened volumes. I'll touch on senior and the Medicare Advantage environment as a whole in just a minute. Timothy DankerChief Executive Office at SelectQuote00:04:19Along with others in the industry, we were pleased to see the higher than anticipated final rate notice that came through in April for the 2026 plan year. We believe the increase will progressively help carriers with the Medicare Advantage pressures they faced in the most recent season. For SelectQuote, we expect these higher carrier reimbursement levels to create a less disruptive market backdrop for our customer base and seniors more broadly as we prepare for the next AEP. Turning to Healthcare Services, we delivered strong profitability despite rapid growth. As I alluded to earlier, we believe the scale of our membership now provides SelectQuote with a great foundation and we see an opportunity to drive more consistent margins and cash flows going forward. Timothy DankerChief Executive Office at SelectQuote00:05:05In our Life Insurance business, we drove another impressive quarter on both the top and bottom line. Life revenues grew 13% and profits more than doubled compared to a year ago. The business continues to drive a stable and strong source of EBITDA margin profitability and a highly visible source of cash flow. Across our entire platform, SelectQuote continues to generate highly attractive revenue compared to the cost to acquire customers. For the third quarter, our trailing twelve month revenue to CAC was 5.8x, which compares to 4.2x a year ago. Timothy DankerChief Executive Office at SelectQuote00:05:40We take a lot of pride in this metric as the financial barometer of SelectQuote's overall marketing efficiency and as an indicator of the value we provide to our customer base. When we leverage our superior data and agent led capabilities, our customers receive better service and care. Clearly, the economic outcome is good for our business, but the metric is especially rewarding given the tangible benefit to Americans, particularly in what has been a volatile and confusing year for healthcare policy. SelectQuote continues to solidify our reputation and the healthcare ecosystem as a trusted and valuable partner, which is more important now than ever. Now on Slide four, let me focus on Medicare Advantage and SelectQuote's performance through the OEP period. Timothy DankerChief Executive Office at SelectQuote00:06:26As noted, we're very pleased with our execution through such a unique and challenging Medicare Advantage season. While our agent force was smaller compared to a year ago, the team drove impressive volume and efficiency results. Third quarter policies totaled $168,000 down less than 10% compared to an agent force that was 26% smaller. As we noted last quarter, carrier plan terminations and significant changes to policy features created noise and decision stress for seniors this Medicare Advantage season. That backdrop made our agent led model all the more important. Timothy DankerChief Executive Office at SelectQuote00:07:02We're very proud that we were able to help so many people. Even more impressive are the efficiency and profitability improvements in senior during 3Q. As you can see at the right of this page, our strong close rates year to date serve as a testament to how our technology arms our agents with new data and tools in each unique season. Looking forward to fourth quarter, as we exit the OEP season, we're refining our approach due to the introduction of changes to beneficiary eligibility during the special election period. Although we're pleased with the continued performance of our agents, these industry changes present a headwind to close rates and volume relative to prior years. Timothy DankerChief Executive Office at SelectQuote00:07:43In addition to throughput, our senior segment also drove efficiency across both marketing and operating expenses. Marketing expenses per approved policy was down 9% and overall operating expenses per policy were down four percent. We focus each season on optimal profitability, but are especially proud of our operating expense performance given a lower year for policy volume. Again, SelectQuote's technology and information advantages continue to benefit our overall business, not just through incremental revenue opportunity, but also through operating efficiency. The combination of each of these factors contributed to the strong 27% adjusted EBITDA margins despite lower year over year policy volume. Timothy DankerChief Executive Office at SelectQuote00:08:29For a year where Medicare Advantage posed challenges for many industry participants, we're proud that our platform not only succeeded, but improved on a very strong fiscal twenty twenty four. Specifically, our year to date senior margins are currently at 30%, which compares to 26% at this point last year. The past three years' results across a wide range of selling seasons gives us a great deal of conviction and our ability to consistently drive profit margins above our long term target of 20%. On Slide five, I'd like to expand on our plan to drive higher profitability in our Healthcare Services segment. As I noted, we believe 106,000 members and our SelectRx business represents critical mass. Timothy DankerChief Executive Office at SelectQuote00:09:15Having created a revenue base of nearly $675,000,000 over the past year, we see an opportunity to focus on generating more consistent margins and cash flows to drive shareholder value. As we've discussed, SelectRX profitability has lagged membership and revenue, given growth investment and the seasoning of our member base. We're proud of the progress we've made to date, but believe there is an opportunity to better identify the customers who will benefit from the SelectRx offering the most. You have heard us speak to the ramp of SelectRx members to full box shipments. While that continues to be a focus for new members, we've also observed a wide range of customer use cases. Timothy DankerChief Executive Office at SelectQuote00:09:54We'll share more when we speak to our 2026 outlook, but we believe there's an opportunity to align SelectRx's best service attributes with those Americans that need us the most. Over the remainder of fiscal twenty twenty five and into fiscal twenty twenty six, we plan to increase the mix of members that benefit most from SelectRx, who typically also have the most attractive unit economics. Now that we've achieved meaningful scale, our primary goal will be to increase efficiency and build a more consistent margin profile for the business. In the near term, this will likely translate to slower membership growth. As we've announced last September, membership and volume growth required additional investment in facility expansion with the opening of our Olathe facility here in Kansas, which shipped its first box on April 7. Timothy DankerChief Executive Office at SelectQuote00:10:43In the medium and long term, we believe the scale and efficiency gains of this new facility will be accretive, but we expect the near term headwind to profitability, which will dampen our fourth quarter results. Ryan will share more about the pacing of this dynamic in our outlook, but I'll close this topic by emphasizing three unchanged attributes about SelectRx and our healthcare services capabilities. First, our SelectRx members drive visible revenue and cash flow. It has been clear to us that the value of our medication management adherence solution is widely proven. Our job now is to improve efficiency and drive a more consistent margin profile for the business. Timothy DankerChief Executive Office at SelectQuote00:11:23Second, regardless of the membership mix, there remains significant operating leverage potential in healthcare services, which should continue to grow as we broaden our value added service offering. Third, while less visible, we know from our policyholders and agents that there's a halo effect to the differentiated value we deliver. Policyholders that are also SelectRX members become further attached to SelectQuote. As a result, insurance providers and caregivers increasingly seek us out for partnership. In the past, we've called this concept a healthcare information hub or flywheel. Timothy DankerChief Executive Office at SelectQuote00:11:57Whatever we call it, we know that it is a reality with our customers and partners. Finally, before I turn the call over to Ryan, I'd like to briefly comment on the Department of Justice complaint that was recently filed against many participants in the Medicare Advantage system. We've been cooperating fully with the Department of Justice's inquiries since we first received the previously disclosed subpoena in 2022. However, we firmly reject these allegations, which we believe represent a misunderstanding of our industry and our business. We plan to mount a vigorous defense as this case moves forward. Timothy DankerChief Executive Office at SelectQuote00:12:33SelectQuote has a forty year history as a high integrity organization that has helped millions of Americans find the right coverage for their health needs. Additionally, we've invested significant capital into compliance across our whole organization from our agents to our management and take significant measures to fully comply with all federal laws and regulations. I assure you that the culture at SelectQuote is one where the customers' needs are prioritized. We look forward to detailing this history as the matter develops. We've always been and we will continue to be a compliant and fair dealing standard bearer in the Medicare Advantage industry. Timothy DankerChief Executive Office at SelectQuote00:13:12We will continue to deliver high quality advice to the customers we help to navigate the complicated array of Medicare health plan options. This is obviously an active legal matter, so we won't be commenting further on any particulars at this point. And with that, I'd like to hand the call over to Ryan. Ryan? Ryan ClementChief Financial Officer at SelectQuote00:13:31Thanks, Tim. Starting on Slide six, SelectQuote generated $4.00 $8,000,000 in revenue for the third quarter, up 8% compared to a year ago. Similar to last quarter, our top line growth was driven by our SelectRx business, But as Tim mentioned, operating performance across each of our businesses was very strong. For senior specifically, the OEP period was similar to AEP where agents delivered higher Medicare Advantage volumes than originally forecasted, driven by impressive productivity and close rates. Consolidated adjusted EBITDA totaled $38,000,000 for an overall margin of 9%. Ryan ClementChief Financial Officer at SelectQuote00:14:07We are pleased to have maintained healthy consolidated margins despite a significant mix shift from the growth in SelectRx, which is still a lower margin business. As Tim noted, we see healthcare services as a strategic opportunity, not just for our new revenue streams, but for scaled profitability in the coming years. Moving to Slide seven. Our senior results were quite strong despite operating with a smaller agent population for the season. Revenue totaled $169,000,000 in Q3, driven by the strong agent efficiency we mentioned. Ryan ClementChief Financial Officer at SelectQuote00:14:41Similar to last quarter's AEP, we continue to see seniors seek our tenured agents for much needed answers in such a confusing and volatile Medicare Advantage backdrop. The end result with high value service to our customers, but also significant operating efficiency in both marketing and agent throughput. Put more plainly, more seniors came to us when they needed us most and our aligned model drove very strong margins. Our adjusted EBITDA in Q3 was $46,000,000 which declined by 26%, in line with the 26% reduction in agent headcount compared to last year. Despite a smaller agent population, the senior business drove attractive EBITDA margins of 27%. Ryan ClementChief Financial Officer at SelectQuote00:15:23The performance since our strategic redesign has exceeded our expectations in three distinctly different Medicare Advantage environments. As originally intended, our strategic redesign was undertaken to build a SelectQuote for all seasons. We firmly believe that goal has been achieved, and we see a highly durable value creation engine for customers and shareholders as a result. On Slide eight, I'll briefly review our senior operating performance. As mentioned, with a 26% reduction in our agent workforce compared to last year, we're very pleased with the increased agent level efficiency, which led to only a 10% decline in our Medicare Advantage approved policy generation. Ryan ClementChief Financial Officer at SelectQuote00:16:00The difference again was a combination of seniors proactively seeking us out and our tenured agents' ever improving ability to leverage SelectQuote's data and tools to provide the most effective and valuable service possible. We are proud of the division's strong results. It is worth noting, on the heels of meaningful progress on the capital structure, we've already begun planning for the next AEP and OEP seasons. Next, let me speak to LTV, which was $915,000,000 for Q3, down 8% compared to a year ago. The key driver was a shift in our commission structure. Ryan ClementChief Financial Officer at SelectQuote00:16:32For a select few carrier partners, you will recall that we had shifted to a higher mix of upfront commissions compared to what was historically been a ratable timeline. The changes in our modeled LTVs is the result of those upfront structures largely reverting back to ratable structures. On Slide nine, as Tim noted, our SelectRx membership continued to grow substantially in Q3. We ended the quarter with 106,000 members, up 41% compared to a year ago. As a result, healthcare services revenue of $190,000,000 grew 53% year over year and has a trailing full year revenue base of $674,000,000 Healthcare Services produced $6,000,000 of adjusted EBITDA, which we are very pleased with. Ryan ClementChief Financial Officer at SelectQuote00:17:16We will provide more detail on our outlook for Healthcare Services in fiscal twenty twenty six in our next earnings call. But as Tim noted, our goal is to drive improvements in both profitability and cash flow in the future. We have confidence in our economics and believe the medium term results will drive value for shareholders. On Slide 10, I'll end the segment review with our Life business, where we continue to be pleased with results. The business performed well on both the top line and from a cash flow perspective. Ryan ClementChief Financial Officer at SelectQuote00:17:44Revenue during the quarter was $46,000,000 and adjusted EBITDA was $6,000,000 which was up 103% year over year. EBITDA margins of 14% nearly doubled compared to 8% last year. Both our final expense and Term Life business contributed to the highly successful quarter with Term Life premiums up 13% and final expense premium up 17% year over year. These results were fueled by strong agent retention and a highly tenured agent force that drove both strong productivity and customer retention. Turning to Slide 11, I will conclude my remarks with an update to our fiscal twenty twenty five outlook. Ryan ClementChief Financial Officer at SelectQuote00:18:21We maintain our full year ranges for revenue and adjusted EBITDA. That said, we do expect to finish the year in or towards the lower half of the ranges based on the following. First, as Tim noted, new beneficiary eligibility parameters during the special election period could drive additional friction for policy volumes and close rates compared to previous seasons. Second, as we ramp our Kansas distribution facility and focus less on member growth and more on achieving consistent margins and cash flow, we could encounter near term headwinds to our healthcare services EBITDA. While accretive in the long term, we expect fiscal fourth quarter EBITDA to potentially take a modest step back. Ryan ClementChief Financial Officer at SelectQuote00:18:59In addition, fourth quarter growth will taper due to seasonal trends as we exit the AEP and OEP seasons. Lastly, we are adjusting our net income expectations to a range of negative $1,000,000 to $28,000,000 to reflect the impact the change in our stock price had on the fair market value of the warrants issued as part of the transactions announced during this fiscal year. I'll conclude by echoing Tim's comments about the strength and potential of our overall model. Fiscal twenty twenty five has been a year of significant progress and transition for our company. In addition to the strong growth and results in all three business lines, we have made meaningful progress on our capital structure, including the $100,000,000 securitization in October and the $350,000,000 strategic investment in February. Ryan ClementChief Financial Officer at SelectQuote00:19:43These deals have lowered our interest expense, extended our maturities and increased our available liquidity. We produced $71,000,000 in operating cash flow during the quarter and ended the quarter with an $86,000,000 cash balance. Our commissions receivable balance of over $1,000,000,000 remains a significant asset and source of future cash flows as we continue to evaluate additional alternatives to further optimize our capital structure. We are proud of the results we delivered this Medicare Advantage season and look forward to sharing updates on the planned scale of our sizable health care services opportunity. With that, we will open the call up for questions. Operator00:20:19Thank you. Ladies and gentlemen, we will now begin the question and answer session. Session. Your first question comes from the line of George Sutton with Craig Hallum. Please go ahead. George SuttonPartner & Senior Research Analyst at Craig-Hallum Capital Group LLC00:20:48Thank you. I wondered if you could walk through the separation of the growth or the decline you saw in Medicare Advantage and obviously the significant growth of SelectRx. And I'm asking from the concept of the feeder of customer opportunities into SelectRx and any adjustments that you might be making there going forward? Timothy DankerChief Executive Office at SelectQuote00:21:13Yeah. I'd be happy to. Good morning, George. Thanks for the call. I think on this two part question, I'm gonna ask our president, Bob Grant, to talk about our Medicare dynamics. Timothy DankerChief Executive Office at SelectQuote00:21:23I'm happy to touch on health care as well. Bob? Robert GrantPresident at SelectQuote00:21:27Yeah. So on the Medicare side, George, SEP was or sorry. OEP was was a really strong quarter for us from a overall close rate perspective and and cost. But but to Ryan's point earlier, we were down 26% on our agent count, which is why we ended up, you know, seeing a little bit lower volume and lower overall EBITDA there. However, one of the reasons for such a strong quarter, which Tim will get into health care services from a growth perspective in the SRX space, is we did have a lot more tenured agents. Robert GrantPresident at SelectQuote00:22:04And we've been very open in the past that they are better at understanding how to deal with customers' needs both on sales and folks that don't buy a policy where they end up transferring them over to health care services. So we did see a little stronger, what I would say, attachment rate or just overall efficiency in that number, which is why you saw one kind of outpace the other. So that also helps our attachment rates in a good way on the the customers that really, really need SelectRX, and and we see that as a as a positive. So that that's why you saw what you saw there. Tim can broadly speak about health care services, but from direct to your question, the reason we didn't see kind of the reduction in both on the growth side was that. Timothy DankerChief Executive Office at SelectQuote00:22:47Yeah. Yeah. Just to add to Bob's good comments there. I mean, overall, we're really pleased with the ability of the model to, you know, leverage our strong m MA growth and have that translate into opportunities for our health care services platform. I think you've seen that through the growth of, you know, critical mass not over a hundred thousand members. Timothy DankerChief Executive Office at SelectQuote00:23:09We will, you know, anticipate, though, that senior health care services will lag our senior just a bit and just in terms of timing, and there is some seasonality that we called out as well. But overall, real really pleased with the the synergy between both sides of the platform. George SuttonPartner & Senior Research Analyst at Craig-Hallum Capital Group LLC00:23:30So I wondered if you can give us thoughts on agent growth going into this next season. Are the plans to take advantage of improvements in that market, particularly from a regulatory perspective? Robert GrantPresident at SelectQuote00:23:48Yeah. Great question. Tiring is underway right now. You know, it's not gonna be the same as as last year per se, but we will talk way more about that in our upcoming guide on the next call. So we feel good about where we are with hiring, though. Timothy DankerChief Executive Office at SelectQuote00:24:05Then Certainly, as we highlighted yeah. George, real quick. Certainly, as we highlighted on the last call, I think the improved capital position that we're in, you know, gives us an opportunity. We're very focused and feel good about where we're at in the early stages of of hiring and and do look forward to sharing more on our fiscal twenty six guide in August. George SuttonPartner & Senior Research Analyst at Craig-Hallum Capital Group LLC00:24:26And then just finishing up on your better financials. Can you talk about receivable securitization? My anticipation has been that we might see additional receivable securitization. Ryan ClementChief Financial Officer at SelectQuote00:24:39Yeah. Great question, George. Obviously, we've we've made great progress, you know, on on the capital structure more broadly with the first securitization. We've been obviously focused on getting the prep across the finish line, which we're happy to share with our last earnings call. And we've, you know, we've hired Jeffries to explore a variety of options. Ryan ClementChief Financial Officer at SelectQuote00:24:59We do see securitization as a potential path. It's not the only path. We look forward to sharing additional updates when the time is right, but we do have several irons in the fire. George SuttonPartner & Senior Research Analyst at Craig-Hallum Capital Group LLC00:25:11Guys. Operator00:25:14Your Operator00:25:15next question comes from the line of Ben Hendrix with RBC Capital Markets. Please go ahead. Michael MurrayEquity Research Associate at RBC Capital Markets00:25:23Hi. This is Michael Murray on for Ben. Appreciate your commentary on MA LTV and the impact of the shifting commission structure. Just wanted to see how should we think about MA LTV moving forward? Do you anticipate an ongoing headwind as the shift continues? Michael MurrayEquity Research Associate at RBC Capital Markets00:25:39Thanks. Ryan ClementChief Financial Officer at SelectQuote00:25:43Yeah. So we, I mean, as as you noted, yeah, we did see a shift, from upfront to ratable, which did lead to a decline. That's simply a continuation of changes we had announced in prior quarters. All that said, we do expect, you know, in the fourth quarter, it will be down year over year. You know, we'll look forward to sharing additional details, on our longer term outlook, you know, on our next earnings call. Ryan ClementChief Financial Officer at SelectQuote00:26:08But, in fourth quarter, we do expect it to be down year over year. Michael MurrayEquity Research Associate at RBC Capital Markets00:26:14Okay. And then just shifting to SelectRX, obviously, another great quarter. It's exciting to hear about the new facility opening in Kansas. Obviously, we heard your commentary on fourth quarter margin expectations. But just longer term, bigger picture, how should investors, think about the growth and margin targets, for this business? Michael MurrayEquity Research Associate at RBC Capital Markets00:26:38Thanks. Timothy DankerChief Executive Office at SelectQuote00:26:40Yes, Michael, I'll I'll comment on that, and and Ryan, have you add to it here. But, yeah, I do think just stepping back, you know, we're really pleased with the progress. We've got critical, you know, critical mass and scale here with over a hundred thousand patients. And so I think we'd ask investors to to also think that part of our job now is to further prioritize, efficiency and consistency of margins. So we are spending a lot of time, focused on that and and analyzing that, and I think we are finding that those, you know, members that generally benefit the most from our adherence solution also have the best unit economics. Timothy DankerChief Executive Office at SelectQuote00:27:21Again, customers with multiple products, they're juggling a lot of prescription drugs. And so we're seeing some opportunities to refine that so that we can drive, even improved margins and cash flow profile. We had mentioned on the call, you know, some investment in the Kansas facility. You know, we think longer term, that is certainly gonna drive these efficiency gains, but there is some, you know, near term costs there in the fourth quarter as we as we scale that up. Ryan? Ryan ClementChief Financial Officer at SelectQuote00:27:53No. You said it well. Yeah. Think for the fiscal twenty twenty five, we still expect single digit EBITDA margins for the year. And as we refine our membership parameters and scale the cadence, we do see a path to margin enhancement and expansion in future quarters. Michael MurrayEquity Research Associate at RBC Capital Markets00:28:12All right. Thank you. Operator00:28:16Your next question comes from the line of Pat McCann with Noble Capital Markets. Please go ahead. Patrick McCannEquity Research Analyst at Noble Capital Markets00:28:23Hey, guys. Thanks for taking my questions. I wanted to ask about the final rate notice. Could you I know it's early, but could you give your kind of your view on how you think the the upcoming AEP, how the environment should look relative to the one that we just came out of as far as market dynamics. What would be your early read given the final rate notice and how that changes? Patrick McCannEquity Research Analyst at Noble Capital Markets00:28:53Thanks. Timothy DankerChief Executive Office at SelectQuote00:28:55Good morning, Pat. Great question. We definitely believe the final rate notice was a positive development as the carrier reimbursement rates were substantially higher than the preliminary rates. As we've been in discussions with carriers, they definitely had felt like this was a step in the right direction. This helps improve revenues. Timothy DankerChief Executive Office at SelectQuote00:29:18And you've heard many carriers commented on higher medical cost trends and elevated plan utilization. So we certainly view that as a positive development. We would say to the carriers, some carriers are still focused on increasing margins. They're in the middle innings of a multiyear plan to get to their target profitability, but we certainly believe this is a positive development. Bob, anything you'd like to add? Robert GrantPresident at SelectQuote00:29:45No. I mean, I I think that, to Tim's point, it Robert GrantPresident at SelectQuote00:29:50was a little bit, I think, up in Robert GrantPresident at SelectQuote00:29:52the air as far as what CMS was gonna do, right, just coming in, early and then also the rate, they feel it, frankly, get a little bit higher too in December, I think, than people anticipated. But it was great that they took into account this year versus a lagging year like they had in the past with where inflation's gone and other things. So I I think those, that CMS has support, for the private side of Medicare. Now do they wanna clean some things up that we're very supportive of, frankly, as far as making sure that everyone has access to quality health care, especially a lot of the focus that we have, which we've talked about in the past, rural areas, things like that, yes. But as far as just the advanced rate notice and the rate notice, very positive from all kind of sides. Patrick McCannEquity Research Analyst at Noble Capital Markets00:30:37Thanks. And then I just wanted to briefly touch on the Healthcare Services segment. First of all, congrats on opening the new facility. And with that, I'm wondering maybe if you could reiterate the benefits you expect to realize, the incremental benefits from that facility as well as maybe if you could touch on the profitability drag that you mentioned for fiscal Q4. And would that go beyond Q4? Patrick McCannEquity Research Analyst at Noble Capital Markets00:31:13Or what's sort of the timeframe for the initial drag on profitability before you sort of get through that? Thanks. Ryan ClementChief Financial Officer at SelectQuote00:31:27Yeah. So with respect to the Kansas facility, we're obviously really excited about having it open. And longer term, you know, see benefits in operating efficiency, throughput, and even customer experience. You know, with that all being said, there is a short term lag as in terms of profitability or drag on profitability as a result of simply, you know, investments into the facility. As we scale up, we will outgrow, and we'll we'll see margin expansion. Ryan ClementChief Financial Officer at SelectQuote00:31:57But in the near term, you know, I think on a quarterly basis, you can think of it as low single digit million dollar investment. And again, that will scale into it over the next couple of quarters. Patrick McCannEquity Research Analyst at Noble Capital Markets00:32:09Great. Thanks, guys. That's all I had. I'll jump back in the queue. 00:32:33I will now turn the call back over to Tim for closing remarks. Timothy DankerChief Executive Office at SelectQuote00:32:39Thank you, everyone, and we appreciate your time and support this morning. Most of all, thank you to our incredible teams at SelectQuote for another season of world class service and execution. Our customers needed you more than ever this year. And because of our high touch and information driven approach, they received the help they needed and our business benefited as well. Looking ahead, we're energized and have conviction that our overall business can generate additional operating leverage and resulting value to our shareholders. Timothy DankerChief Executive Office at SelectQuote00:33:09We'll share more on our view for fiscal twenty twenty six on the next call and hope to see and speak to many of you between now and then. Thank you again for your time this morning. Have a good day. 00:33:21Ladies and gentlemen, that concludes today's call. Thank you all for joining. You may now disconnect.Read moreParticipantsExecutivesMatthew GunterChief Communication Officer & Investor RelationsTimothy DankerChief Executive OfficeRyan ClementChief Financial OfficerAnalystsGeorge SuttonPartner & Senior Research Analyst at Craig-Hallum Capital Group LLCRobert GrantPresident at SelectQuoteMichael MurrayEquity Research Associate at RBC Capital MarketsPatrick McCannEquity Research Analyst at Noble Capital MarketsPowered by